Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,2.7457364181249674e-08,6.648512144958476,115.75479450568301,"['RPL41', 'RPL3', 'RPS7', 'RPL35A', 'RPSA', 'RPL10A', 'RPS26', 'RPL7A', 'RPS15A', 'RPS27', 'RPL18A', 'RPL26', 'RPL15', 'FAU', 'RPS27A', 'RPS21']",8.621612352912398e-06,0,0,16
2,"GPCRs, Class A Rhodopsin-like WP455",2.1648054067312212e-05,3.5735978835978837,38.38256752117524,"['GPR65', 'GPR87', 'OPRL1', 'GPR4', 'GPR3', 'SSTR1', 'GPR6', 'MCHR1', 'HCRTR2', 'HCRTR1', 'MC4R', 'OPN1SW', 'GPR171', 'RHO', 'ACKR4', 'OR7C1', 'GPR18']",0.003398744488568017,0,0,17
3,Platelet-mediated interactions with vascular and circulating cells WP4462,9.515317059616364e-05,14.51268115942029,134.38775614243977,"['SELP', 'IL1B', 'CCL2', 'SELE', 'TLR2']",0.009959365189065128,0,0,5
4,Spinal Cord Injury WP2431,0.00020753539706150635,3.773660846404262,32.001431331442646,"['SELP', 'EGR1', 'NR4A1', 'ZFP36', 'VCAN', 'FCGR2A', 'IL1B', 'LEP', 'CCL2', 'CXCL1', 'LTB', 'TNFSF13B']",0.01629152866932825,0,0,12
5,Selenium Micronutrient Network WP15,0.0007287239582759822,4.0976277372262775,29.60214604082932,"['SERPINA3', 'SELENOM', 'IL1B', 'SELENOW', 'DIO3', 'CCL2', 'KMO', 'SEPHS2', 'SELENOH']",0.04576386457973168,0,0,9
6,Pre-implantation embryo WP3527,0.002025935880844588,5.123732251521298,31.775970823706885,"['EGR1', 'ZFP36', 'FOXD1', 'GATA2', 'AQP3', 'TBX3']",0.10602397776420013,0,0,6
7,Hematopoietic Stem Cell Differentiation WP2849,0.004651651172563331,4.247089548935417,22.809134710461226,"['IL1B', 'LEF1', 'GATA2', 'CD34', 'FLI1', 'RUNX1']",0.20865978116926942,0,0,6
8,Nonalcoholic fatty liver disease WP4396,0.007229952161266844,2.503205128205128,12.339606901585583,"['SOCS3', 'NDUFB11', 'UQCRQ', 'NDUFA4', 'IL1B', 'LEP', 'CYCS', 'CCL2', 'UQCR11', 'COX7A1', 'COX7C']",0.28377562232972364,0,0,11
9,Glycolysis and Gluconeogenesis WP534,0.011586062723319189,4.02475845410628,17.942181580143814,"['LDHC', 'TPI1', 'PGAM1', 'ALDOB', 'ALDOA']",0.39793260311928513,0,0,5
10,Cori Cycle WP1946,0.012673012838193795,7.229241877256317,31.579356465685446,"['TPI1', 'PGAM1', 'ALDOA']",0.39793260311928513,0,0,3
11,White fat cell differentiation WP4149,0.015340087261175396,4.631320072332731,19.346347548337604,"['EGR2', 'MECOM', 'EBF1', 'GATA2']",0.4037657518384378,0,0,4
12,Thyroxine (Thyroid Hormone) Production WP1981,0.015430538286819279,14.43963963963964,60.23360993525493,"['TRH', 'CGA']",0.4037657518384378,0,0,2
13,COVID-19 adverse outcome pathway WP4891,0.021126341511304166,11.550990990990991,44.55488216396297,"['IL1B', 'CCL2']",0.4575844879470499,0,0,2
14,Mitochondrial CIV Assembly WP4922,0.021470204965608204,4.134332213898218,15.880338487469709,"['PET100', 'NDUFA4', 'COX14', 'COX7C']",0.4575844879470499,0,0,4
15,Kynurenine Pathway and links to Cellular Senescence WP5044,0.024443405546743128,5.42057761732852,20.11790364282075,"['IL1R2', 'KMO', 'ACMSD']",0.4575844879470499,0,0,3
16,Apoptosis Modulation and Signaling WP1772,0.025459760473941433,2.5701035673187573,9.433966321161675,"['BCL2A1', 'BAG3', 'IL1R2', 'CASP4', 'CYCS', 'TNFRSF10D', 'HSPA1A']",0.4575844879470499,0,0,7
17,Peptide GPCRs WP24,0.0256572695942229,3.217995169082126,11.787285678808882,"['MC4R', 'OPRL1', 'SSTR1', 'HCRTR2', 'HCRTR1']",0.4575844879470499,0,0,5
18,Dual hijack model of Vif in HIV infection WP3300,0.02754903800588021,9.625225225225226,34.57176520899137,"['ELOB', 'RUNX1']",0.4575844879470499,0,0,2
19,Proximal tubule transport WP4917,0.027688233347114486,3.1478418399495904,11.290514620898602,"['SLC22A6', 'SLC3A1', 'ATP6V0A4', 'SLC22A8', 'ATP6V1B1']",0.4575844879470499,0,0,5
20,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.030002541460256396,2.475609756097561,8.680659227682286,"['UQCRQ', 'NDUFA4', 'UCP1', 'UQCR11', 'SLC25A5', 'COX7A1', 'COX7C']",0.4710399009260254,0,0,7
21,IL1 and megakaryocytes in obesity WP2865,0.03193708111501997,4.817689530685921,16.59206265204627,"['IL1B', 'CCL2', 'TLR2']",0.47348611173713745,0,0,3
22,Circadian rhythm related genes WP3594,0.03426884016660951,1.949298668810864,6.575995681982491,"['PER2', 'EGR1', 'MAGEL2', 'EGR3', 'LEP', 'CRH', 'OPRL1', 'CARTPT', 'RPS27A', 'HCRTR2', 'HCRTR1']",0.47348611173713745,0,0,11
23,Adipogenesis WP236,0.0349296102664561,2.2317500350287234,7.486227795622453,"['SOCS3', 'EGR2', 'CYP26B1', 'GADD45B', 'LEP', 'EBF1', 'UCP1', 'GATA2']",0.47348611173713745,0,0,8
24,Prader-Willi and Angelman Syndrome WP3998,0.036816324395663326,2.895289855072464,9.559708387777157,"['PCSK1', 'MAGEL2', 'ATP10A', 'CGA', 'TYR']",0.47348611173713745,0,0,5
25,Vitamin B12 metabolism WP1533,0.037697938832574635,3.4034677162004043,11.15707721362895,"['SERPINA3', 'TCN1', 'IL1B', 'CCL2']",0.47348611173713745,0,0,4
26,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.0415103821620796,2.040602189781022,6.492811943821689,"['ADCYAP1', 'EGR1', 'SST', 'IL1B', 'SSTR1', 'GATA2', 'TAC1', 'ALDOA', 'YWHAH']",0.49260508693739335,0,0,9
27,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.04235776225257841,7.218018018018018,22.820511653496663,"['SOCS3', 'CHI3L1']",0.49260508693739335,0,0,2
28,IL-18 signaling pathway WP4754,0.04581271851137445,1.7497957516339868,5.394958939660447,"['SLC12A3', 'NRN1', 'FUT1', 'SOCS3', 'NR4A1', 'ARL4D', 'IL1B', 'HMOX1', 'CYCS', 'CCL2', 'LTB', 'IL18R1', 'TGM2']",0.5012183160191226,0,0,13
29,Complement system WP2806,0.05205425435359599,2.348261146809241,6.940212439430649,"['SELP', 'FKBP2', 'CD93', 'CFH', 'SELE', 'TLR2']",0.5012183160191226,0,0,6
30,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.05524474342291714,3.769188510437922,10.915502400376239,"['EGR2', 'RAB25', 'NEFL']",0.5012183160191226,0,0,3
31,Oxidation by Cytochrome P450 WP43,0.0553887469101991,2.966198358603422,8.5823355370345,"['CYP39A1', 'CYP26B1', 'CYP3A5', 'CYP2C18']",0.5012183160191226,0,0,4
32,Sulfation Biotransformation Reaction WP692,0.05944990115715622,5.773693693693693,16.296950906124962,"['SULT1B1', 'SULT4A1']",0.5012183160191226,0,0,2
33,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.05944990115715622,5.773693693693693,16.296950906124962,"['SST', 'DKK1']",0.5012183160191226,0,0,2
34,Transcriptional cascade regulating adipogenesis WP4211,0.05944990115715622,5.773693693693693,16.296950906124962,"['EGR2', 'GATA2']",0.5012183160191226,0,0,2
35,Computational Model of Aerobic Glycolysis WP4629,0.05944990115715622,5.773693693693693,16.296950906124962,"['TPI1', 'ALDOA']",0.5012183160191226,0,0,2
36,EDA signaling in hair follicle development WP3930,0.05944990115715622,5.773693693693693,16.296950906124962,"['LTB', 'DKK1']",0.5012183160191226,0,0,2
37,LTF danger signal response pathway WP4478,0.05944990115715622,5.773693693693693,16.296950906124962,"['IL1B', 'TLR2']",0.5012183160191226,0,0,2
38,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.06065699365836515,3.611913357400722,10.122460644935774,"['BCL2A1', 'IL1B', 'SELE']",0.5012183160191226,0,0,3
39,Ovarian infertility WP34,0.06630670146565358,3.4672202166064983,9.408178309153048,"['EGR1', 'GJA4', 'PGR']",0.5229189190485313,0,0,3
40,VEGFA-VEGFR2 Signaling Pathway WP3888,0.06661387503802947,1.4782255243928952,4.004279961317133,"['EGR1', 'FLT1', 'EGR3', 'NFATC1', 'GATA2', 'RPL10A', 'DKK1', 'FUT1', 'SELE', 'APOLD1', 'NR4A1', 'NR4A3', 'RPL18A', 'CCL2', 'DNAJB9', 'CYCS', 'RPL26', 'ALDOA', 'TMSB10', 'HSPA1A']",0.5229189190485313,0,0,20
41,Metapathway biotransformation Phase I and II WP702,0.07167102392133959,1.9003254800083609,5.008628468174199,"['CYP39A1', 'SULT1B1', 'CYP26B1', 'GLYAT', 'GAL3ST2', 'CYP2C18', 'SULT4A1', 'CYP3A5']",0.5474797721703497,0,0,8
42,Sleep regulation WP3591,0.07829254393982973,3.209987966305656,8.176811670902731,"['CRH', 'HCRTR2', 'HCRTR1']",0.5474797721703497,0,0,3
43,Cytokines and Inflammatory Response WP530,0.07846047690339407,4.8108108108108105,12.244284493666823,"['IL1B', 'CXCL1']",0.5474797721703497,0,0,2
44,Nephrogenesis WP5052,0.07846047690339407,4.8108108108108105,12.244284493666823,"['FOXD1', 'PAX2']",0.5474797721703497,0,0,2
45,Phytochemical activity on NRF2 transcriptional activation WP3,0.07846047690339407,4.8108108108108105,12.244284493666823,"['HMOX1', 'SLC7A11']",0.5474797721703497,0,0,2
46,Heart Development WP1591,0.08461485329120857,3.0951521402784943,7.6439284218469865,"['FOXC1', 'NFATC1', 'FGF10']",0.5676455851702241,0,0,3
47,Selective expression of chemokine receptors during T-cell polarization WP4494,0.08858163590235982,4.440471240471241,10.762950570980175,"['IL4R', 'IL18R1']",0.5676455851702241,0,0,2
48,Leptin Insulin Overlap WP3935,0.08858163590235982,4.440471240471241,10.762950570980175,"['SOCS3', 'LEP']",0.5676455851702241,0,0,2
49,Mitochondrial complex III assembly WP4921,0.08858163590235982,4.440471240471241,10.762950570980175,"['UQCRQ', 'UQCR11']",0.5676455851702241,0,0,2
50,Complement and Coagulation Cascades WP558,0.09652710700779496,2.4086799276672695,5.631328455790346,"['VWF', 'CFH', 'SERPIND1', 'TFPI']",0.5943041490283847,0,0,4
51,Phosphodiesterases in neuronal function WP4222,0.09652710700779496,2.4086799276672695,5.631328455790346,"['ADCY10', 'PDE10A', 'PDE6C', 'PDE5A']",0.5943041490283847,0,0,4
52,Blood Clotting Cascade WP272,0.10986792652033615,3.847927927927928,8.498057642810592,"['F8A1', 'VWF']",0.6631123783860258,0,0,2
53,Genes controlling nephrogenesis WP4823,0.11192661163840563,2.707581227436823,5.92936428435321,"['FOXC1', 'FOXD1', 'PAX2']",0.6631123783860258,0,0,3
54,Cardiac Progenitor Differentiation WP2406,0.119221151474017,2.625369215621923,5.583569862545944,"['MESP1', 'THY1', 'DKK1']",0.6782629231228295,0,0,3
55,Apoptosis Modulation by HSP70 WP384,0.12096408820024987,3.6072072072072072,7.619365155817735,"['CYCS', 'HSPA1A']",0.6782629231228295,0,0,2
56,BMP Signaling Pathway in Eyelid Development WP3927,0.12096408820024987,3.6072072072072072,7.619365155817735,"['FOXC1', 'FGF10']",0.6782629231228295,0,0,2
57,22q11.2 copy number variation syndrome WP4657,0.12423472529616379,1.826764733976502,3.8098686645673663,"['CLDN5', 'CYP26B1', 'FOXC1', 'VWF', 'SERPIND1', 'FGF10']",0.6796362690366726,0,0,6
58,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.12668628602383303,2.5479932045020175,5.264259542363517,"['CASP5', 'IL1B', 'NOD2']",0.6796362690366726,0,0,3
59,Gastric acid production WP2596,0.1277023562839608,9.609712230215827,19.777297703390385,['VIP'],0.6796362690366726,0,0,1
60,GDNF/RET signaling axis WP4830,0.13231947005262112,3.3948065712771593,6.866118682549352,"['FOXC1', 'PAX2']",0.6886598506784541,0,0,2
61,Differentiation Pathway WP2848,0.13431386237453266,2.4750386797318207,4.968828156746634,"['FST', 'DKK1', 'FGF10']",0.6886598506784541,0,0,3
62,Oncostatin M Signaling Pathway WP2374,0.13597742274542726,2.101200065757028,4.1924539250313675,"['SOCS3', 'EGR1', 'CCL2', 'OSMR']",0.6886598506784541,0,0,4
63,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.14390423722076814,3.206006006006006,6.2151863903814695,"['FCGR2A', 'IL1B']",0.7060301638643937,0,0,2
64,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.14390423722076814,3.206006006006006,6.2151863903814695,"['H2AFZ', 'DUSP6']",0.7060301638643937,0,0,2
65,Pathways in clear cell renal cell carcinoma WP4018,0.1465490250697588,1.8527034559643256,3.557922943154368,"['LDHC', 'FLT1', 'TPI1', 'ALDOB', 'ALDOA']",0.7079445211062194,0,0,5
66,Vitamin A and carotenoid metabolism WP716,0.1500235994239978,2.340960093667675,4.440713904421205,"['CYP26B1', 'RBP2', 'NPC1L1']",0.7137486396838683,0,0,3
67,Globo Sphingolipid Metabolism WP1424,0.15569025959361793,3.0370791844476055,5.648623366980079,"['A4GALT', 'FUT1']",0.7189226692999415,0,0,2
68,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.15569025959361793,3.0370791844476055,5.648623366980079,"['IL4R', 'CCL2']",0.7189226692999415,0,0,2
69,NO/cGMP/PKG mediated Neuroprotection WP4008,0.16628494404244817,2.220633157456262,3.9839323162788425,"['IL1B', 'NEFL', 'CYCS']",0.7520346266624485,0,0,3
70,NRF2-ARE regulation WP4357,0.16765103142156496,2.885045045045045,5.15231728100322,"['HMOX1', 'SLC7A11']",0.7520346266624485,0,0,2
71,FTO Obesity Variant Mechanism WP3407,0.1853115714903335,5.765107913669064,9.718338689161977,['UCP1'],0.7970936088762292,0,0,1
72,Hfe effect on hepcidin production WP3924,0.1853115714903335,5.765107913669064,9.718338689161977,['HAMP'],0.7970936088762292,0,0,1
73,let-7 inhibition of ES cell reprogramming WP3299,0.1853115714903335,5.765107913669064,9.718338689161977,['EGR1'],0.7970936088762292,0,0,1
74,Lung fibrosis WP3624,0.19156962705063368,2.0616297060340383,3.4068512300025278,"['IL1B', 'HMOX1', 'CCL2']",0.8128765255932293,0,0,3
75,Folate Metabolism WP176,0.200204117183514,2.013558895138947,3.2386440628470714,"['SERPINA3', 'IL1B', 'CCL2']",0.8381459657414152,0,0,3
76,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.20433955570004966,2.508264786525656,3.98305470142326,"['LEF1', 'DKK1']",0.8381459657414152,0,0,2
77,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.21267578944380147,4.803956834532374,7.436459789137142,['IL1B'],0.8381459657414152,0,0,1
78,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.21267578944380147,4.803956834532374,7.436459789137142,['VIP'],0.8381459657414152,0,0,1
79,Nanomaterial-induced inflammasome activation WP3890,0.21267578944380147,4.803956834532374,7.436459789137142,['IL1B'],0.8381459657414152,0,0,1
80,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.2266184092241629,1.881886673991524,2.7936376064615356,"['CXCL17', 'CCL2', 'CXCL1']",0.8381459657414152,0,0,3
81,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.2292526989254159,2.307315315315315,3.3985148589310894,"['IL1B', 'CXCL1']",0.8381459657414152,0,0,2
82,Leptin signaling pathway WP2034,0.2369676517488509,1.6493929217256522,2.37484811165592,"['SOCS3', 'CISH', 'IL1B', 'LEP']",0.8381459657414152,0,0,4
83,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.23912247697318442,4.117420349434738,5.891120226815101,['TLR2'],0.8381459657414152,0,0,1
84,HIF1A and PPARG regulation of glycolysis WP2456,0.23912247697318442,4.117420349434738,5.891120226815101,['TPI1'],0.8381459657414152,0,0,1
85,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.23912247697318442,4.117420349434738,5.891120226815101,['ELOB'],0.8381459657414152,0,0,1
86,Mitochondrial CII Assembly WP4920,0.23912247697318442,4.117420349434738,5.891120226815101,['SDHAF1'],0.8381459657414152,0,0,1
87,NAD Biosynthesis II (from tryptophan) WP2485,0.23912247697318442,4.117420349434738,5.891120226815101,['KMO'],0.8381459657414152,0,0,1
88,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.24178700809714548,2.2184338184338186,3.1495062153312405,"['GGT5', 'TRPA1']",0.8381459657414152,0,0,2
89,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.2445793923627026,1.8032490974729243,2.539362986147273,"['BEX3', 'SOCS3', 'YBX3']",0.8381459657414152,0,0,3
90,Oxidative phosphorylation WP623,0.2445793923627026,1.8032490974729243,2.539362986147273,"['ATP6AP1', 'NDUFA4', 'ATP6AP2']",0.8381459657414152,0,0,3
91,Vitamin B12 Disorders WP4271,0.264682345236504,3.602517985611511,4.788556498318899,['TCN1'],0.8381459657414152,0,0,1
92,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.264682345236504,3.602517985611511,4.788556498318899,['CYP2C18'],0.8381459657414152,0,0,1
93,Estrogen Receptor Pathway WP2881,0.264682345236504,3.602517985611511,4.788556498318899,['PDK4'],0.8381459657414152,0,0,1
94,Fatty Acid Omega Oxidation WP206,0.264682345236504,3.602517985611511,4.788556498318899,['ADH1B'],0.8381459657414152,0,0,1
95,Irinotecan pathway WP229,0.264682345236504,3.602517985611511,4.788556498318899,['CYP3A5'],0.8381459657414152,0,0,1
96,Leptin and adiponectin WP3934,0.264682345236504,3.602517985611511,4.788556498318899,['LEP'],0.8381459657414152,0,0,1
97,Macrophage markers WP4146,0.264682345236504,3.602517985611511,4.788556498318899,['CD163'],0.8381459657414152,0,0,1
98,PTF1A related regulatory pathway WP4147,0.264682345236504,3.602517985611511,4.788556498318899,['FGF10'],0.8381459657414152,0,0,1
99,Base Excision Repair WP4752,0.26692546679662904,2.05971685971686,2.720444801191488,"['FEN1', 'POLE3']",0.8381459657414152,0,0,2
100,Type II interferon signaling (IFNG) WP619,0.26692546679662904,2.05971685971686,2.720444801191488,"['SOCS3', 'IL1B']",0.8381459657414152,0,0,2
101,Tamoxifen metabolism WP691,0.28938507946742364,3.202038369304556,3.970518045134445,['CYP3A5'],0.8822030577938934,0,0,1
102,Dopamine metabolism WP2436,0.28938507946742364,3.202038369304556,3.970518045134445,['TYR'],0.8822030577938934,0,0,1
103,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.28938507946742364,3.202038369304556,3.970518045134445,['HMOX1'],0.8822030577938934,0,0,1
104,Hepatitis B infection WP4666,0.30093040808294946,1.3424218123496392,1.612082463001345,"['EGR2', 'EGR3', 'ATP6AP1', 'CYCS', 'NFATC1', 'TLR2']",0.8935063898206625,0,0,6
105,Vitamin D Receptor Pathway WP2877,0.31271190568689594,1.321760574112301,1.5365109024311583,"['IL1RL1', 'COL13A1', 'CASP5', 'PNOC', 'CYP3A5', 'S100A8']",0.8935063898206625,0,0,6
106,Serotonin Transporter Activity WP1455,0.313259372991033,2.881654676258993,3.34480506207159,['IL1B'],0.8935063898206625,0,0,1
107,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.313259372991033,2.881654676258993,3.34480506207159,['HSD11B2'],0.8935063898206625,0,0,1
108,Role of Osx and miRNAs in tooth development WP3971,0.313259372991033,2.881654676258993,3.34480506207159,['DKK1'],0.8935063898206625,0,0,1
109,Parkinson's disease pathway WP2371,0.3170684681495657,1.8018018018018018,2.069617190222262,"['PINK1', 'CYCS']",0.8935063898206625,0,0,2
110,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.31940720441494364,1.424418994039247,1.625672999082798,"['MC4R', 'UCP1', 'DIO3', 'TRH']",0.8935063898206625,0,0,4
111,Serotonin and anxiety-related events WP3944,0.33633296023330395,2.619522563767168,2.854372340190452,['CRH'],0.8935063898206625,0,0,1
112,ACE Inhibitor Pathway WP554,0.33633296023330395,2.619522563767168,2.854372340190452,['ATP6AP2'],0.8935063898206625,0,0,1
113,Iron metabolism in placenta WP2007,0.33633296023330395,2.619522563767168,2.854372340190452,['HAMP'],0.8935063898206625,0,0,1
114,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.33633296023330395,2.619522563767168,2.854372340190452,['PGR'],0.8935063898206625,0,0,1
115,RalA downstream regulated genes WP2290,0.33633296023330395,2.619522563767168,2.854372340190452,['YBX3'],0.8935063898206625,0,0,1
116,Tryptophan metabolism WP465,0.34187072566838794,1.695601483836778,1.81992740760709,"['CYP2C18', 'ACMSD']",0.8935063898206625,0,0,2
117,Nuclear receptors WP170,0.34187072566838794,1.695601483836778,1.81992740760709,"['NR4A1', 'PGR']",0.8935063898206625,0,0,2
118,Regulation of toll-like receptor signaling pathway WP1449,0.3434805236821391,1.3111001317523057,1.4010742059399048,"['CISH', 'IL1B', 'PELI3', 'CD180', 'TLR2']",0.8935063898206625,0,0,5
119,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.34581518517502724,1.466040506638928,1.5567162753138537,"['CCL2', 'NOD2', 'TLR2']",0.8935063898206625,0,0,3
120,p53 transcriptional gene network WP4963,0.34581518517502724,1.466040506638928,1.5567162753138537,"['CCL2', 'SLC7A11', 'TNFRSF10D']",0.8935063898206625,0,0,3
121,Vitamin D-sensitive calcium signaling in depression WP4698,0.35416697726475294,1.647052767052767,1.7096190144183305,"['CALB1', 'PVALB']",0.8935063898206625,0,0,2
122,Farnesoid X receptor pathway WP2879,0.3586326489272824,2.4010791366906474,2.4622026313438914,['FKBP5'],0.8935063898206625,0,0,1
123,Ganglio Sphingolipid Metabolism WP1423,0.3586326489272824,2.4010791366906474,2.4622026313438914,['FUT1'],0.8935063898206625,0,0,1
124,Ferroptosis WP4313,0.3663810367598392,1.6012012012012011,1.607736348730938,"['HMOX1', 'SLC7A11']",0.8935063898206625,0,0,2
125,IL-2 signaling pathway WP49,0.3663810367598392,1.6012012012012011,1.607736348730938,"['SOCS3', 'CISH']",0.8935063898206625,0,0,2
126,Cells and molecules involved in local acute inflammatory response  WP4493,0.38018435072650786,2.2162423907028224,2.143325822877618,['SELP'],0.8935063898206625,0,0,1
127,Nephrotic syndrome WP4758,0.39052987693741875,1.516737790422001,1.4261139256672712,"['EMP2', 'PAX2']",0.8935063898206625,0,0,2
128,MAPK Signaling Pathway WP382,0.3917416168210148,1.148617660357858,1.0764302534132164,"['DUSP4', 'NR4A1', 'DUSP2', 'IL1R2', 'IL1B', 'NFATC1', 'DUSP6', 'HSPA1A', 'FGF10']",0.8935063898206625,0,0,9
129,Nuclear Receptors Meta-Pathway WP2882,0.3941961263517688,1.1356144467316356,1.0571511094781032,"['EGR1', 'GADD45B', 'IL1B', 'PDK4', 'HMOX1', 'CCL2', 'SLC7A11', 'CYP3A5', 'HSPA1A', 'FKBP5']",0.8935063898206625,0,0,10
130,Tryptophan catabolism leading to NAD+ production WP4210,0.40101311131942685,2.0578108941418294,1.8803476607461953,['KMO'],0.8935063898206625,0,0,1
131,Development and heterogeneity of the ILC family WP3893,0.40101311131942685,2.0578108941418294,1.8803476607461953,['IL1B'],0.8935063898206625,0,0,1
132,Galanin receptor pathway WP4970,0.40101311131942685,2.0578108941418294,1.8803476607461953,['UCP1'],0.8935063898206625,0,0,1
133,ID signaling pathway WP53,0.40101311131942685,2.0578108941418294,1.8803476607461953,['PAX2'],0.8935063898206625,0,0,1
134,Major receptors targeted by epinephrine and norepinephrine WP4589,0.40101311131942685,2.0578108941418294,1.8803476607461953,['ADCY10'],0.8935063898206625,0,0,1
135,Overview of nanoparticle effects WP3287,0.40101311131942685,2.0578108941418294,1.8803476607461953,['HMOX1'],0.8935063898206625,0,0,1
136,Development of ureteric collection system WP5053,0.4024498984135222,1.4777546777546777,1.3450296475989576,"['FOXC1', 'PAX2']",0.8935063898206625,0,0,2
137,IL-6 signaling pathway WP364,0.4024498984135222,1.4777546777546777,1.3450296475989576,"['SOCS3', 'VIP']",0.8935063898206625,0,0,2
138,Regulatory circuits of the STAT3 signaling pathway WP4538,0.40998329511855336,1.3099770265835249,1.1680264274915544,"['SOCS3', 'DUSP2', 'OSMR']",0.8935063898206625,0,0,3
139,Eukaryotic Transcription Initiation WP405,0.4142581425561074,1.4407207207207207,1.269658138731544,"['POLR2I', 'POLR2K']",0.8935063898206625,0,0,2
140,Hepatitis C and Hepatocellular Carcinoma WP3646,0.4142581425561074,1.4407207207207207,1.269658138731544,"['LEF1', 'CD44']",0.8935063898206625,0,0,2
141,Metabolic reprogramming in colon cancer WP4290,0.4142581425561074,1.4407207207207207,1.269658138731544,"['PGAM1', 'ALDOB']",0.8935063898206625,0,0,2
142,Serotonin and anxiety WP3947,0.4211431391511403,1.9205035971223021,1.6608179117773376,['CRH'],0.8935063898206625,0,0,1
143,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.4211431391511403,1.9205035971223021,1.6608179117773376,['SYTL4'],0.8935063898206625,0,0,1
144,Dopaminergic Neurogenesis WP2855,0.4211431391511403,1.9205035971223021,1.6608179117773376,['SLC18A2'],0.8935063898206625,0,0,1
145,Glutathione metabolism WP100,0.4211431391511403,1.9205035971223021,1.6608179117773376,['GGT5'],0.8935063898206625,0,0,1
146,Hypertrophy Model WP516,0.4211431391511403,1.9205035971223021,1.6608179117773376,['NR4A3'],0.8935063898206625,0,0,1
147,Mammalian disorder of sexual development WP4842,0.4211431391511403,1.9205035971223021,1.6608179117773376,['FST'],0.8935063898206625,0,0,1
148,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.4211431391511403,1.9205035971223021,1.6608179117773376,['LEF1'],0.8935063898206625,0,0,1
149,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.4369288133461845,1.252786061842725,1.0372880619993914,"['GADD45B', 'LEF1', 'CYCS']",0.904233462428674,0,0,3
150,Regulation of Microtubule Cytoskeleton WP2038,0.4375160819751744,1.371943371943372,1.1341057591423358,"['PARD6A', 'RHO']",0.904233462428674,0,0,2
151,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.4405978336037807,1.8003597122302157,1.475615799119438,['TLR2'],0.904233462428674,0,0,1
152,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.4405978336037807,1.8003597122302157,1.475615799119438,['LEF1'],0.904233462428674,0,0,1
153,Cancer immunotherapy by PD-1 blockade WP4585,0.4405978336037807,1.8003597122302157,1.475615799119438,['NFATC1'],0.904233462428674,0,0,1
154,Nanomaterial induced apoptosis WP2507,0.459399811616331,1.694350402031316,1.3179240263066825,['CYCS'],0.9246893644072303,0,0,1
155,Nicotine Activity on Dopaminergic Neurons WP1602,0.459399811616331,1.694350402031316,1.3179240263066825,['SLC18A2'],0.9246893644072303,0,0,1
156,Nucleotide metabolism WP404,0.459399811616331,1.694350402031316,1.3179240263066825,['OAZ1'],0.9246893644072303,0,0,1
157,Exercise-induced Circadian Regulation WP410,0.4714326965854214,1.2802402402402402,0.9627136863680849,"['PER2', 'CLDN5']",0.9281902935661769,0,0,2
158,Netrin-UNC5B signaling pathway WP4747,0.4714326965854214,1.2802402402402402,0.9627136863680849,"['CCL2', 'SELE']",0.9281902935661769,0,0,2
159,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.477570934122002,1.6001199040767387,1.1825567373525707,['EGR1'],0.9281902935661769,0,0,1
160,Transcription factor regulation in adipogenesis WP3599,0.477570934122002,1.6001199040767387,1.1825567373525707,['LEP'],0.9281902935661769,0,0,1
161,TGF-beta Receptor Signaling WP560,0.48246298129009746,1.2523305914610263,0.9127625089389798,"['FST', 'LEF1']",0.9281902935661769,0,0,2
162,Alzheimer's disease WP2059,0.48931178953454196,1.1521299638989169,0.8234910973933636,"['ATP5MD', 'IL1B', 'CYCS']",0.9281902935661769,0,0,3
163,Synaptic Vesicle Pathway WP2267,0.49334997929473573,1.225608587310715,0.8659371521923005,"['SLC32A1', 'SLC18A2']",0.9281902935661769,0,0,2
164,Vitamin D in inflammatory diseases WP4482,0.4951323311502474,1.5158084059068535,1.0655075309126605,['NFATC1'],0.9281902935661769,0,0,1
165,Imatinib and Chronic Myeloid Leukemia WP3640,0.4951323311502474,1.5158084059068535,1.0655075309126605,['FLT1'],0.9281902935661769,0,0,1
166,IL-4 signaling pathway WP395,0.5040908654813795,1.2,0.8219984862087406,"['SOCS3', 'IL4R']",0.9281902935661769,0,0,2
167,Urea cycle and metabolism of amino groups WP497,0.5121044262559057,1.4399280575539568,0.9636383269726317,['CKM'],0.9281902935661769,0,0,1
168,Differentiation of white and brown adipocyte WP2895,0.5121044262559057,1.4399280575539568,0.9636383269726317,['LEP'],0.9281902935661769,0,0,1
169,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.5251247333173351,1.1518558558558558,0.7419327688063754,"['FST', 'LEF1']",0.9281902935661769,0,0,2
170,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.5285069600308493,1.3712744090441933,0.8744607367245258,['LEF1'],0.9281902935661769,0,0,1
171,Inflammatory Response Pathway WP453,0.5285069600308493,1.3712744090441933,0.8744607367245258,['IL4R'],0.9281902935661769,0,0,1
172,NAD+ biosynthetic pathways WP3645,0.5285069600308493,1.3712744090441933,0.8744607367245258,['ACMSD'],0.9281902935661769,0,0,1
173,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.5285069600308493,1.3712744090441933,0.8744607367245258,['HMOX1'],0.9281902935661769,0,0,1
174,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.5285069600308493,1.3712744090441933,0.8744607367245258,['BCL2A1'],0.9281902935661769,0,0,1
175,Pyrimidine metabolism WP4022,0.531081302502075,1.079783393501805,0.6833302927059232,"['POLE3', 'POLR2I', 'POLR2K']",0.9281902935661769,0,0,3
176,Constitutive Androstane Receptor Pathway WP2875,0.5443590129556937,1.3088620013080445,0.7959795826665986,['CYP3A5'],0.9281902935661769,0,0,1
177,Zinc homeostasis WP3529,0.5443590129556937,1.3088620013080445,0.7959795826665986,['SLC30A2'],0.9281902935661769,0,0,1
178,DNA Mismatch Repair WP531,0.5443590129556937,1.3088620013080445,0.7959795826665986,['POLE3'],0.9281902935661769,0,0,1
179,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.5443590129556937,1.3088620013080445,0.7959795826665986,['CGA'],0.9281902935661769,0,0,1
180,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.5443590129556937,1.3088620013080445,0.7959795826665986,['IL1B'],0.9281902935661769,0,0,1
181,RAS and bradykinin pathways in COVID-19 WP4969,0.5443590129556937,1.3088620013080445,0.7959795826665986,['IL1B'],0.9281902935661769,0,0,1
182,"Relationship between inflammation, COX-2 and EGFR WP4483",0.5443590129556937,1.3088620013080445,0.7959795826665986,['PLA1A'],0.9281902935661769,0,0,1
183,Cytosolic DNA-sensing pathway WP4655,0.5555281546969347,1.086452490226075,0.6386558726420397,"['IL1B', 'POLR2K']",0.9281902935661769,0,0,2
184,IL-1 signaling pathway WP195,0.5555281546969347,1.086452490226075,0.6386558726420397,"['IL1B', 'CCL2']",0.9281902935661769,0,0,2
185,Angiogenesis WP1539,0.5596790273867928,1.2518767594619957,0.7265790370438237,['FLT1'],0.9281902935661769,0,0,1
186,Unfolded protein response WP4925,0.5596790273867928,1.2518767594619957,0.7265790370438237,['IL1B'],0.9281902935661769,0,0,1
187,Gastric Cancer Network 1 WP2361,0.5596790273867928,1.2518767594619957,0.7265790370438237,['GATD3A'],0.9281902935661769,0,0,1
188,MTHFR deficiency WP4288,0.5596790273867928,1.2518767594619957,0.7265790370438237,['CYCS'],0.9281902935661769,0,0,1
189,Pregnane X receptor pathway WP2876,0.5596790273867928,1.2518767594619957,0.7265790370438237,['CYP3A5'],0.9281902935661769,0,0,1
190,NRF2 pathway WP2884,0.5629833466527763,1.0099933377748167,0.5802464557636822,"['EGR1', 'HMOX1', 'SLC7A11', 'HSPA1A']",0.9281902935661769,0,0,4
191,Canonical and non-canonical Notch signaling WP3845,0.574484828982222,1.1996402877697843,0.6649385253937035,['LEF1'],0.9281902935661769,0,0,1
192,EPO Receptor Signaling WP581,0.574484828982222,1.1996402877697843,0.6649385253937035,['CISH'],0.9281902935661769,0,0,1
193,Photodynamic therapy-induced unfolded protein response WP3613,0.574484828982222,1.1996402877697843,0.6649385253937035,['DNAJB9'],0.9281902935661769,0,0,1
194,7-oxo-C and 7beta-HC pathways WP5064,0.5887936471033299,1.1515827338129496,0.6099697680274018,['HSD11B2'],0.9281902935661769,0,0,1
195,Ethanol effects on histone modifications WP3996,0.5887936471033299,1.1515827338129496,0.6099697680274018,['ADH1B'],0.9281902935661769,0,0,1
196,Endoderm differentiation WP2853,0.6023269244589678,0.9591320072332731,0.4862366873048809,"['DUSP4', 'DUSP2', 'LEF1', 'DKK1']",0.9281902935661769,0,0,4
197,Monoamine Transport WP727,0.6026221349503745,1.1072219147758715,0.5607690590985953,['IL1B'],0.9281902935661769,0,0,1
198,Pathways Regulating Hippo Signaling WP4540,0.6084982360884992,0.9592057761732852,0.47649627509818715,"['FLT1', 'LEF1', 'CDH17']",0.9281902935661769,0,0,3
199,Senescence and Autophagy in Cancer WP615,0.6157551472443654,0.9486055460784703,0.4599844096625761,"['IL1B', 'CXCL1', 'CD44']",0.9281902935661769,0,0,3
200,16p11.2 distal deletion syndrome WP4950,0.615986388545162,1.0661470823341328,0.516580685280212,['PLN'],0.9281902935661769,0,0,1
201,Signal transduction through IL1R WP4496,0.615986388545162,1.0661470823341328,0.516580685280212,['IL1B'],0.9281902935661769,0,0,1
202,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.615986388545162,1.0661470823341328,0.516580685280212,['PGR'],0.9281902935661769,0,0,1
203,Oxidative Stress WP408,0.615986388545162,1.0661470823341328,0.516580685280212,['HMOX1'],0.9281902935661769,0,0,1
204,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.6209783272904046,0.9592792792792793,0.45705733951297806,"['NEFL', 'PFN2']",0.9281902935661769,0,0,2
205,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.6289019655286056,1.028006166495375,0.4767685889691285,['TLR2'],0.9281902935661769,0,0,1
206,Endometrial cancer WP4155,0.6296970999886734,0.9434943139861173,0.4363815641672459,"['GADD45B', 'LEF1']",0.9281902935661769,0,0,2
207,Glucocorticoid Receptor Pathway WP2880,0.6296970999886734,0.9434943139861173,0.4363815641672459,"['GADD45B', 'CCL2']",0.9281902935661769,0,0,2
208,Ectoderm Differentiation WP2858,0.6334270822533601,0.9204773960216999,0.4202995417156303,"['STC1', 'CCL2', 'NFATC1', 'LY6E']",0.9281902935661769,0,0,4
209,Mesodermal commitment pathway WP2857,0.6334270822533601,0.9204773960216999,0.4202995417156303,"['FOXC1', 'LEF1', 'DKK1', 'TBX3']",0.9281902935661769,0,0,4
210,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.6382589687038621,0.9282185411217669,0.41678049403357803,"['EGR1', 'CGA']",0.9281902935661769,0,0,2
211,Toll-like Receptor Signaling related to MyD88 WP3858,0.6413839030629429,0.9924956586454974,0.4407942073257599,['TLR2'],0.9281902935661769,0,0,1
212,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.6413839030629429,0.9924956586454974,0.4407942073257599,['ADAMTS2'],0.9281902935661769,0,0,1
213,Endothelin Pathways WP2197,0.6413839030629429,0.9924956586454974,0.4407942073257599,['ADCY10'],0.9281902935661769,0,0,1
214,GABA receptor Signaling WP4159,0.6413839030629429,0.9924956586454974,0.4407942073257599,['SLC32A1'],0.9281902935661769,0,0,1
215,Aryl Hydrocarbon Receptor Pathway WP2873,0.6534467351866281,0.9593525179856115,0.4081989860956685,['IL1B'],0.9281902935661769,0,0,1
216,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.6534467351866281,0.9593525179856115,0.4081989860956685,['CCL2'],0.9281902935661769,0,0,1
217,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.6534467351866281,0.9593525179856115,0.4081989860956685,['LEF1'],0.9281902935661769,0,0,1
218,Prion disease pathway WP3995,0.6534467351866281,0.9593525179856115,0.4081989860956685,['EBF1'],0.9281902935661769,0,0,1
219,"GPCRs, Other WP117",0.6549148752241459,0.8990990990990991,0.3805437056359459,"['OR10A2', 'GPR18']",0.9281902935661769,0,0,2
220,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.6549148752241459,0.8990990990990991,0.3805437056359459,"['DKK1', 'PAX2']",0.9281902935661769,0,0,2
221,DNA damage response WP707,0.6630106704981339,0.8852113652113652,0.3637901758080775,"['GADD45B', 'CYCS']",0.9281902935661769,0,0,2
222,MECP2 and Associated Rett Syndrome WP3584,0.6630106704981339,0.8852113652113652,0.3637901758080775,"['SST', 'FKBP5']",0.9281902935661769,0,0,2
223,Fatty acid beta-oxidation WP143,0.6651045097209866,0.9283476444650731,0.37859046775807137,['TPI1'],0.9281902935661769,0,0,1
224,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.6651045097209866,0.9283476444650731,0.37859046775807137,['NFATC1'],0.9281902935661769,0,0,1
225,Melatonin metabolism and effects WP3298,0.6651045097209866,0.9283476444650731,0.37859046775807137,['PER2'],0.9281902935661769,0,0,1
226,The influence of laminopathies on Wnt signaling WP4844,0.6763708045073407,0.8992805755395683,0.35163113844208693,['LEF1'],0.930678438829648,0,0,1
227,CAMKK2  Pathway WP4874,0.6763708045073407,0.8992805755395683,0.35163113844208693,['HMOX1'],0.930678438829648,0,0,1
228,Type 2 papillary renal cell carcinoma WP4241,0.6763708045073407,0.8992805755395683,0.35163113844208693,['ELOB'],0.930678438829648,0,0,1
229,miRNA regulation of DNA damage response WP1530,0.6787431926496477,0.8586795750974855,0.332749014773688,"['GADD45B', 'CYCS']",0.930678438829648,0,0,2
230,Amyotrophic lateral sclerosis (ALS) WP2447,0.6872587429275712,0.8719751471550032,0.32702942239302546,['NEFL'],0.938257588170684,0,0,1
231,Non-small cell lung cancer WP4255,0.6938717913361817,0.8336858597728163,0.3046855657008781,"['GADD45B', 'CYCS']",0.940024703398119,0,0,2
232,Wnt signaling WP428,0.6956347592935098,0.8374575023658477,0.30393889310778816,"['LEF1', 'NFATC1', 'DKK1']",0.940024703398119,0,0,3
233,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.6977810091001967,0.8462759204401185,0.30453236118917276,['BCL2A1'],0.940024703398119,0,0,1
234,Breast cancer pathway WP4262,0.7014220165707948,0.8392180673433561,0.2976249549961743,"['GADD45B', 'LEF1', 'PGR', 'FGF10']",0.940024703398119,0,0,4
235,Oxysterols derived from cholesterol WP4545,0.7079498628943259,0.8220452209660842,0.28391962490556055,['CYP39A1'],0.940024703398119,0,0,1
236,Acute viral myocarditis WP4298,0.7154567458270685,0.7987987987987988,0.2674651047428722,"['CYCS', 'NOD2']",0.940024703398119,0,0,2
237,Prolactin Signaling Pathway WP2037,0.7154567458270685,0.7987987987987988,0.2674651047428722,"['SOCS3', 'CISH']",0.940024703398119,0,0,2
238,Myometrial relaxation and contraction pathways WP289,0.7169224139578931,0.8210798243347972,0.273245228077644,"['RGS4', 'IL1B', 'CRH', 'YWHAH']",0.940024703398119,0,0,4
239,Calcium Regulation in the Cardiac Cell WP536,0.721955810915009,0.815205263360394,0.2655868197565463,"['RGS4', 'PLN', 'GJA4', 'YWHAH']",0.940024703398119,0,0,4
240,Hippo-Merlin Signaling Dysregulation WP4541,0.7249869341081138,0.7984356197352587,0.2567782096993229,"['FLT1', 'CDH17', 'CD44']",0.940024703398119,0,0,3
241,Oxidative Damage WP3941,0.7272743344432309,0.7775131246354268,0.2476002373409603,['CYCS'],0.940024703398119,0,0,1
242,Apoptosis WP254,0.729126229035048,0.7771122473825176,0.24549629312523602,"['CASP4', 'CYCS']",0.940024703398119,0,0,2
243,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.729126229035048,0.7771122473825176,0.24549629312523602,"['LEF1', 'DKK1']",0.940024703398119,0,0,2
244,T-cell receptor (TCR) signaling pathway WP69,0.7357498420445133,0.7667027027027027,0.23527430656082093,"['IL1B', 'NFATC1']",0.940024703398119,0,0,2
245,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.736452474636743,0.7570049223778872,0.23157581019564258,['CCL2'],0.940024703398119,0,0,1
246,Hedgehog Signaling Pathway WP4249,0.736452474636743,0.7570049223778872,0.23157581019564258,['EVC2'],0.940024703398119,0,0,1
247,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.7453222729734613,0.7375484228002214,0.21679393089152194,['CISH'],0.9436741682002696,0,0,1
248,Fas ligand pathway and stress induction of heat shock proteins WP314,0.7453222729734613,0.7375484228002214,0.21679393089152194,['CYCS'],0.9436741682002696,0,0,1
249,Toll-like Receptor Signaling Pathway WP75,0.7608784506532951,0.7276998517504847,0.19886702133334253,"['IL1B', 'TLR2']",0.9595013393780507,0,0,2
250,Corticotropin-releasing hormone signaling pathway WP2355,0.7668284229865321,0.7185585585585585,0.19077169360641846,"['NR4A1', 'CRH']",0.9595891206131738,0,0,2
251,Interleukin-11 Signaling Pathway WP2332,0.7701833066886867,0.6847379239465571,0.178803376241378,['SOCS3'],0.9595891206131738,0,0,1
252,Prostaglandin Synthesis and Regulation WP98,0.7701833066886867,0.6847379239465571,0.178803376241378,['HSD11B2'],0.9595891206131738,0,0,1
253,Nucleotide Excision Repair WP4753,0.7779197418282352,0.6687719591768446,0.16794998596892124,['POLE3'],0.9595891206131738,0,0,1
254,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.7783431158533225,0.7009448472863107,0.17564824758493355,"['LEF1', 'DKK1']",0.9595891206131738,0,0,2
255,Pancreatic adenocarcinoma pathway WP4263,0.7839117331400365,0.6924563117334201,0.1685846175033157,"['GADD45B', 'DUSP6']",0.9595891206131738,0,0,2
256,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.7853961910751135,0.6535317200784827,0.15787168820964745,['EIF4A2'],0.9595891206131738,0,0,1
257,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.7853961910751135,0.6535317200784827,0.15787168820964745,['ADCY10'],0.9595891206131738,0,0,1
258,TNF-alpha signaling pathway WP231,0.7998863056742677,0.6681751518960821,0.14919394269658376,"['CCL2', 'SELE']",0.9735050386888373,0,0,2
259,Wnt Signaling Pathway WP363,0.819173888882404,0.5866612832183233,0.11701481371158504,['LEF1'],0.9880181970402293,0,0,1
260,Mitochondrial complex I assembly model OXPHOS system WP4324,0.819173888882404,0.5866612832183233,0.11701481371158504,['NDUFB11'],0.9880181970402293,0,0,1
261,Small cell lung cancer WP4658,0.8241920784886965,0.6312642312642313,0.12205599413131678,"['GADD45B', 'CYCS']",0.9880181970402293,0,0,2
262,Translation Factors WP107,0.8252636911569688,0.5748920863309352,0.11040935782112744,['EIF4A2'],0.9880181970402293,0,0,1
263,Interferon type I signaling pathways WP585,0.8311487563946721,0.563584426576386,0.10423296221751453,['SOCS3'],0.9880181970402293,0,0,1
264,RANKL/RANK signaling pathway WP2018,0.8311487563946721,0.563584426576386,0.10423296221751453,['NFATC1'],0.9880181970402293,0,0,1
265,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.8368359560922635,0.5527116768123962,0.09845299336500225,['LEF1'],0.9880181970402293,0,0,1
266,Wnt signaling pathway and pluripotency WP399,0.8374715864176491,0.6110024918535557,0.10837225485706041,"['LEF1', 'CD44']",0.9880181970402293,0,0,2
267,Modulators of TCR signaling and T cell activation WP5072,0.8423319310396616,0.5422492194923306,0.09303973113054825,['ELOB'],0.9880181970402293,0,0,1
268,Genotoxicity pathway WP4286,0.847643099831851,0.5321742605915267,0.08796606616866985,['RPS27'],0.9880181970402293,0,0,1
269,PPAR signaling pathway WP3942,0.847643099831851,0.5321742605915267,0.08796606616866985,['UCP1'],0.9880181970402293,0,0,1
270,Thermogenesis WP4321,0.8613418701707369,0.5741261261261261,0.08569624244676036,"['ADCY10', 'UCP1']",0.9880181970402293,0,0,2
271,Endochondral Ossification with Skeletal Dysplasias WP4808,0.8625287706767326,0.5040704278682318,0.07454534910679557,['SCIN'],0.9880181970402293,0,0,1
272,Endochondral Ossification WP474,0.8625287706767326,0.5040704278682318,0.07454534910679557,['SCIN'],0.9880181970402293,0,0,1
273,Proteasome Degradation WP183,0.8671607047712403,0.4953485487472091,0.07060250522143838,['H2AFZ'],0.9880181970402293,0,0,1
274,Male infertility WP4673,0.875426758186106,0.5519057519057519,0.07342763178728066,"['CYP26B1', 'ETV5']",0.9880181970402293,0,0,2
275,3q29 copy number variation syndrome WP4906,0.8759624060706364,0.4787769784172662,0.06340544279539531,['HAMP'],0.9880181970402293,0,0,1
276,Allograft Rejection WP2328,0.8759624060706364,0.4787769784172662,0.06340544279539531,['IL1B'],0.9880181970402293,0,0,1
277,Integrated breast cancer pathway WP1984,0.8781700108525217,0.5933150753143284,0.0770805694604239,"['RHO', 'FAU', 'TFPI']",0.9880181970402293,0,0,3
278,Gastrin signaling pathway WP4659,0.8787360487916058,0.5466151866151866,0.07066133446248202,"['EGR1', 'CD44']",0.9880181970402293,0,0,2
279,AMP-activated protein kinase (AMPK) signaling WP1403,0.8801424606941042,0.4708986908833589,0.06012034101694016,['LEP'],0.9880181970402293,0,0,1
280,AGE/RAGE pathway WP2324,0.884181889707976,0.463274541656997,0.05702561221704437,['CYCS'],0.9880181970402293,0,0,1
281,Pathways affected in adenoid cystic carcinoma WP3651,0.884181889707976,0.463274541656997,0.05702561221704437,['INSRR'],0.9880181970402293,0,0,1
282,Melanoma WP4685,0.8918576036227908,0.4487410071942446,0.051357868141637675,['GADD45B'],0.9881059973372208,0,0,1
283,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.8955028641080516,0.4418096292197012,0.04876246654921256,['HSPA1A'],0.9881059973372208,0,0,1
284,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.8990254609925912,0.43508829300196206,0.04631250495494675,['ANGPTL1'],0.9881059973372208,0,0,1
285,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.903573093453271,0.6380963304299718,0.06470186520268251,"['IL4R', 'FLT1', 'VWF', 'HIF3A', 'OSMR', 'FGF10']",0.9881059973372208,0,0,6
286,16p11.2 proximal deletion syndrome WP4949,0.9057190071189903,0.42223867964451967,0.04181267830512505,['ALDOA'],0.9881059973372208,0,0,1
287,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9088977874788946,0.41609321238661245,0.03974632052912357,['LEF1'],0.9881059973372208,0,0,1
288,Cell cycle WP179,0.9101400110735659,0.49443926685305994,0.0465548354696267,"['GADD45B', 'YWHAH']",0.9881059973372208,0,0,2
289,Ebola Virus Pathway on Host WP4217,0.9101400110735659,0.49443926685305994,0.0465548354696267,"['SOCS3', 'SCIN']",0.9881059973372208,0,0,2
290,DNA Repair Pathways Full Network WP4946,0.9125819720630384,0.49018249018249016,0.04484060265060313,"['FEN1', 'POLE3']",0.9881059973372208,0,0,2
291,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9283465570588774,0.37760318061340403,0.02807486097423271,['CISH'],0.9929863521059239,0,0,1
292,PI3K-Akt signaling pathway WP4172,0.9288689864982816,0.6016620498614959,0.044395184523929085,"['IL4R', 'FLT1', 'VWF', 'OSMR', 'TLR2', 'FGF10']",0.9929863521059239,0,0,6
293,DNA IR-damage and cellular response via ATR WP4016,0.9330992062817022,0.3678749308245711,0.025473040980154515,['FEN1'],0.9929863521059239,0,0,1
294,TGF-beta Signaling Pathway WP366,0.9338017193109932,0.4513016953961836,0.030910174483369468,"['PARD6A', 'CITED1']",0.9929863521059239,0,0,2
295,Amino Acid metabolism WP3925,0.935356178240271,0.3631955195337401,0.024271587663004787,['PDK4'],0.9929863521059239,0,0,1
296,Ciliopathies WP4803,0.9394589879835425,0.4935267023527947,0.030821292402930033,"['EVC2', 'DNAH11', 'CCDC65']",0.9929863521059239,0,0,3
297,Retinoblastoma gene in cancer WP2446,0.9436490747869879,0.34560544335615845,0.02004543531692598,['H2AFZ'],0.9929863521059239,0,0,1
298,Androgen receptor signaling pathway WP138,0.9455506983429021,0.341469681397739,0.01911812654810203,['ETV5'],0.9929863521059239,0,0,1
299,Neural Crest Differentiation WP2064,0.9455506983429021,0.341469681397739,0.01911812654810203,['MIA'],0.9929863521059239,0,0,1
300,Focal Adhesion WP306,0.9540672188935766,0.4638598887696361,0.021811225390212047,"['FGR', 'FLT1', 'VWF']",0.9940303612471075,0,0,3
301,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9554599919240346,0.4061337933678359,0.018504425282262437,"['EGR1', 'EGR2']",0.9940303612471075,0,0,2
302,Integrin-mediated Cell Adhesion WP185,0.9626803754969523,0.3017228322605074,0.011475674083876735,['RHO'],0.9940303612471075,0,0,1
303,7q11.23 copy number variation syndrome WP4932,0.9651584454875657,0.29546465920047466,0.010478062886024611,['CLDN5'],0.9940303612471075,0,0,1
304,Insulin Signaling WP481,0.970243273525014,0.36912525428654464,0.011150698643150003,"['SOCS3', 'EGR1']",0.9940303612471075,0,0,2
305,Genes related to primary cilium development (based on CRISPR) WP4536,0.9706584708784454,0.2808929327126534,0.008365160586666517,['EVC2'],0.9940303612471075,0,0,1
306,ESC Pluripotency Pathways WP3931,0.9726075617057507,0.27545655783065853,0.007650697449041519,['FGF10'],0.9940303612471075,0,0,1
307,DNA damage response (only ATM dependent) WP710,0.9735330829029935,0.27281603288797535,0.007317873023575253,['LEF1'],0.9940303612471075,0,0,1
308,Osteoblast differentiation WP4787,0.975291517309149,0.2676830498218248,0.006697124898189665,['FGF10'],0.9940303612471075,0,0,1
309,Ras signaling WP4223,0.9796504314277626,0.3402831402831403,0.006996042230929658,"['FLT1', 'PLA1A']",0.9940303612471075,0,0,2
310,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9857483704481583,0.23262853132128444,0.0033391870043147287,['TRIP10'],0.9940303612471075,0,0,1
311,Chemokine signaling pathway WP3929,0.9898983289580329,0.21500243414291123,0.0021829281310893583,['FGR'],0.9940303612471075,0,0,1
312,Regulation of Actin Cytoskeleton WP51,0.9917837689132317,0.20564411779928576,0.001696599001900135,['FGF10'],0.9940303612471075,0,0,1
313,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9928411392751346,0.19984152538109373,0.0014357830867762664,['CLDN5'],0.9940303612471075,0,0,1
314,Ciliary landscape WP4352,0.9940303612471075,0.27282210440105176,0.0016335300649223431,"['NEFL', 'COPS7A']",0.9940303612471075,0,0,2
